TrademarkDir
GLENMARK THERAPEUTICS
LIVE

Serial Number

97345580

Owner

GLENMARK THERAPEUTICS INC., USA

Attorney

Maxim A. Voltchenko

First Use Date

Jul 6, 2022

Filing Date

Apr 4, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

GLENMARK THERAPEUTICS Trademark

Serial Number: 97345580 • Registration: 7444160

GLENMARK THERAPEUTICS is a trademark filed by GLENMARK THERAPEUTICS INC., USA on April 4, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

GLENMARK THERAPEUTICS INC., USA (40 trademarks)

MAHWAH, NJ 07430

Entity Type: 03

Trademark Details

Filing Date

April 4, 2022

Registration Date

July 9, 2024

First Use Anywhere

July 6, 2022

First Use in Commerce

August 1, 2022

Published for Opposition

September 20, 2022

Goods & Services

House mark for pharmaceutical preparations and chemical preparations for pharmaceutical or medical purposes

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 19, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 19, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 19, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 19, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 19, 2025 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 9, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 9, 2024 R.PR
EXPARTE APPEAL TERMINATED
Jun 4, 2024 EXPT
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 4, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 4, 2024 CNPR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 27, 2024 ERFR
EX PARTE APPEAL-INSTITUTED
Apr 30, 2024 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Apr 30, 2024 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Apr 30, 2024 EXAF
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Apr 29, 2024 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
Apr 29, 2024 GNCF
SU - ACTION CONTINUING FINAL - WRITTEN
Apr 29, 2024 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 29, 2024 CRFA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 19, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 18, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 18, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 31, 2024 GNFN
FINAL REFUSAL E-MAILED
Jan 31, 2024 GNFR
SU - FINAL REFUSAL - WRITTEN
Jan 31, 2024 CNFR
ITU LETTER MAILED, NO RESPONSE REQUIRED
Jan 24, 2024 IULN
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 24, 2024 AITU
SOU TEAS EXTENSION RECEIVED
Nov 9, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 19, 2023 EXRA
SOU EXTENSION 1 GRANTED
Sep 18, 2023 EX1G
DIVISIONAL PROCESSING COMPLETE
Sep 18, 2023 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 31, 2023 AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 26, 2023 AITU
TEAS/EMAIL CORRESPONDENCE ENTERED
May 4, 2023 TEME
SOU EXTENSION 1 FILED
May 3, 2023 EXT1
DIVISIONAL REQUEST RECEIVED
May 3, 2023 DRRR
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 3, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 3, 2023 TROA
SOU TEAS EXTENSION RECEIVED
May 3, 2023 EEXT
TEAS REQUEST TO DIVIDE RECEIVED
May 3, 2023 ERTD
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 27, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 27, 2023 GNRT
SU - NON-FINAL ACTION - WRITTEN
Mar 27, 2023 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Feb 16, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 16, 2023 AITU
USE AMENDMENT FILED
Jan 18, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 18, 2023 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 15, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 20, 2022 NPUB
PUBLISHED FOR OPPOSITION
Sep 20, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 31, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 17, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 22, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 22, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 22, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 12, 2022 GNRN
NON-FINAL ACTION E-MAILED
May 12, 2022 GNRT
NON-FINAL ACTION WRITTEN
May 12, 2022 CNRT
ASSIGNED TO EXAMINER
May 11, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 8, 2022 NWOS
NEW APPLICATION ENTERED
Apr 7, 2022 NWAP

Related Trademarks

More from this Owner

Trademark logo

Serial #97404115

Trademark logo

Serial #97404115

Trademark logo

Serial #97404115

GLENMARK THERAPEUTICS

GLENMARK THERAPEUTICS

GLENMARK THERAPEUTICS INC., USA

GLENMARK THERAPEUTICS INC., USA

GLENMARK THERAPEUTICS

GLENMARK THERAPEUTICS